Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Epithelial-to-mesenchymal transition (EMT) is a critical multistep process that converts epithelial cells to more motile and invasive mesenchymal cells, contributing to body patterning and morphogenesis during embryonic development. In addition, both epithelial plasticity and increased motility and invasiveness are essential for the branching morphogenesis that occurs during development of the mammary gland and during tumor formation, allowing cancer cells to escape from the primary tumor. Cripto-1, a member of the epidermal growth factor-Cripto-1/FRL-1/Cryptic (EGF/CFC) gene family, together with the transforming growth factor (TGF)-β family ligand Nodal, regulates both cell movement and EMT during embryonic development. During postnatal development, Cripto-1 regulates the branching morphogenesis of the mouse mammary gland and enhances both the invasive and migratory properties of mammary epithelial cells in vitro. Furthermore, transgenic mouse models have shown that Cripto-1 promotes the formation of mammary tumors that display properties of EMT, including the down-regulation of the cell surface adherens junctional protein E-cadherin and the up-regulation of mesenchymal markers, such as vimentin, N-cadherin, and Snail. Interestingly, Cripto-1 is enriched in a subpopulation of embryonal, melanoma, prostate, and pancreatic cancer cells that possess stem-like characteristics. Therefore, Cripto-1 may play a role during developmental EMT, and it may also be involved in the reprogramming of differentiated tumor cells into cancer stem cells through the induction of an EMT program.

[1]  C. Bianco,et al.  Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. , 2004, The American journal of pathology.

[2]  M. Shen,et al.  Functional redundancy of EGF-CFC genes in epiblast and extraembryonic patterning during early mouse embryogenesis. , 2010, Developmental biology.

[3]  D. Kimelman,et al.  Regulation of canonical Wnt signaling by Brachyury is essential for posterior mesoderm formation. , 2008, Developmental cell.

[4]  M. Klymkowsky,et al.  Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-kappaB via Nodal and Cerberus. , 2009, Developmental biology.

[5]  S. Martinez,et al.  Characterization of the functional properties of the neuroectoderm in mouse Cripto(-/-) embryos showing severe gastrulation defects. , 2009, The International journal of developmental biology.

[6]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[7]  V. Kaartinen,et al.  TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis. , 2002, International journal of molecular medicine.

[8]  B. Zhou,et al.  Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters , 2011, BMC Cancer.

[9]  C. Bianco,et al.  Targeting the embryonic gene Cripto-1 in cancer and beyond , 2010, Expert opinion on therapeutic patents.

[10]  J. Thiery,et al.  Targeted activation of β-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia , 2005, Development.

[11]  A. Ebert,et al.  Identification of Cripto-1 in human milk , 2001, Breast Cancer Research and Treatment.

[12]  R. Cardiff,et al.  Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors , 2002, Oncogene.

[13]  Sendurai A Mani,et al.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression , 2011, Breast Cancer Research.

[14]  M. Trotter,et al.  Activin/Nodal signalling maintains pluripotency by controlling Nanog expression , 2009, Development.

[15]  E. Adamson,et al.  Anterior neural plate regionalization in cripto null mutant mouse embryos in the absence of node and primitive streak. , 2003, Developmental Biology.

[16]  Yoo-Jin Lee,et al.  The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma. , 2011, Oral oncology.

[17]  E. Arenas,et al.  Cripto as a Target for Improving Embryonic Stem Cell–Based Therapy in Parkinson's Disease , 2005, Stem cells.

[18]  K. Kaga,et al.  Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. , 1996, Human pathology.

[19]  W. Abdallah,et al.  Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo , 2005, Journal of Cell Science.

[20]  Maria Cristina Rangel,et al.  Role of Cripto-1 in stem cell maintenance and malignant progression. , 2010, The American journal of pathology.

[21]  L. Nicholson,et al.  Cancer stem cells: problems for therapy? , 2011, The Journal of pathology.

[22]  M. Toyoda,et al.  Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts , 2010, PloS one.

[23]  J. Foidart,et al.  Transactivation of Vimentin by β-Catenin in Human Breast Cancer Cells , 2003 .

[24]  M. Sternlicht,et al.  Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis , 2005, Breast Cancer Research.

[25]  A. Shukla,et al.  Cripto-1 Alters Keratinocyte Differentiation via Blockade of Transforming Growth Factor-β1 Signaling: Role in Skin Carcinogenesis , 2008, Molecular Cancer Research.

[26]  M. Hendrix,et al.  Cripto‐1 Is a Cell Surface Marker for a Tumorigenic, Undifferentiated Subpopulation in Human Embryonal Carcinoma Cells , 2010, Stem cells.

[27]  J. Schlom,et al.  The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. , 2010, The Journal of clinical investigation.

[28]  Deepak Mav,et al.  The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer , 2011, PloS one.

[29]  S. Karlsson,et al.  Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. , 2011, Cell stem cell.

[30]  C. Heisenberg,et al.  Back and forth between cell fate specification and movement during vertebrate gastrulation. , 2008, Current opinion in genetics & development.

[31]  M. Siddiqui,et al.  Signal Transduction in Early Heart Development (I): Cardiogenic Induction and Heart Tube Formation , 2007, Experimental biology and medicine.

[32]  G. D'aiuto,et al.  Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer , 2006, Clinical Cancer Research.

[33]  E. Adamson,et al.  Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells , 2003, The Journal of cell biology.

[34]  A. Ebert,et al.  Development of leiomyosarcoma of the uterus in MMTV‐CR‐1 transgenic mice , 2007, The Journal of pathology.

[35]  D. Salomon,et al.  Detection and location of amphiregulin and Cripto‐1 expression in the developing postnatal mouse mammary gland , 1995, Molecular reproduction and development.

[36]  E. Adamson,et al.  Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. , 1998, Developmental biology.

[37]  Michael K. Wendt,et al.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta. , 2009, Future oncology.

[38]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[39]  A. Califano,et al.  Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling , 2011, Development.

[40]  H. Ford,et al.  Epithelial-mesenchymal transition in development and cancer. , 2009, Future oncology.

[41]  C. Kennedy,et al.  Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[42]  M. Hendrix,et al.  Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells , 2011, The Prostate.

[43]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Varmus,et al.  A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-α , 1999 .

[45]  D. Elliott,et al.  Transforming growth factor Beta2 is required for valve remodeling during heart development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[46]  L. Strizzi,et al.  Msx2 induces epithelial‐mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto‐1 , 2009, Journal of cellular physiology.

[47]  N. Normanno,et al.  Regulation of human cripto‐1 gene expression by TGF‐β1 and BMP‐4 in embryonal and colon cancer cells , 2008, Journal of cellular physiology.

[48]  T. Dale,et al.  Wnt signalling in murine postnatal mammary gland development , 2012, Acta physiologica.

[49]  W. Fischer,et al.  GRP78 and Cripto Form a Complex at the Cell Surface and Collaborate To Inhibit Transforming Growth Factor β Signaling and Enhance Cell Growth , 2007, Molecular and Cellular Biology.

[50]  M. Hendrix,et al.  Expression and functional role of CRIPTO-1 in cutaneous melanoma , 2011, British Journal of Cancer.

[51]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[52]  Peter A. Jones,et al.  DNA methylation and cellular reprogramming. , 2010, Trends in cell biology.

[53]  A. Ebert,et al.  Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. , 2001, Experimental cell research.

[54]  N. Normanno,et al.  Immunohistochemical detection of cripto-1, amphiregulin and transforming growth-factor-alpha in human gastric carcinomas and intestinal metaplasias. , 1994, International journal of oncology.

[55]  D. Pei,et al.  EMT and MET as paradigms for cell fate switching. , 2012, Journal of molecular cell biology.

[56]  M. Hendrix,et al.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells , 2008, Proceedings of the National Academy of Sciences.

[57]  Y. Saijoh,et al.  Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. , 2003, Genes & development.

[58]  Manuel Hidalgo,et al.  Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. , 2011, Cell stem cell.

[59]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[60]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[61]  Y. Yarden,et al.  Expression of amphiregulin, cripto-1, and heregulin-alpha in human breast-cancer cells. , 1993, International journal of oncology.

[62]  W. Vale,et al.  Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling , 2006, Molecular and Cellular Biology.

[63]  Lars Björklund,et al.  Context-dependent neuronal differentiation and germ layer induction of Smad4 −/− and Cripto −/− embryonic stem cells , 2005, Molecular and Cellular Neuroscience.

[64]  P. Carmeliet,et al.  G Protein–Coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-Regulated Kinase/p70S6 Kinase Signaling Pathway , 2009, Circulation research.

[65]  A. Ebert,et al.  Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma , 2005, Oncogene.

[66]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[67]  R. Cardiff,et al.  Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Menotti Ruvo,et al.  A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease , 2010, Stem cells.

[69]  J. C. Belmonte,et al.  Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways , 2009, Oncogene.

[70]  Zhixiang Liao,et al.  The Wnt-inducible Transcription Factor Twist1 Inhibits Chondrogenesis* , 2006, Journal of Biological Chemistry.

[71]  C. Bianco,et al.  An evolving web of signaling networks regulated by Cripto-1 , 2012, Growth factors.

[72]  Mohammad Zafari,et al.  Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. , 2003, The Journal of clinical investigation.

[73]  C. Bianco,et al.  Netrin‐1 can affect morphogenesis and differentiation of the mouse mammary gland , 2008, Journal of cellular physiology.

[74]  K. Satoh,et al.  Msx-1 and Msx-2 in Mammary Gland Development , 2004, Journal of Mammary Gland Biology and Neoplasia.

[75]  A. Casamassimi,et al.  EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[76]  A-P Lu,et al.  Positive association of up‐regulated Cripto‐1 and down‐regulated E‐cadherin with tumour progression and poor prognosis in gastric cancer , 2008, Histopathology.

[77]  W. Vale,et al.  Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling , 2006, Molecular and Cellular Biology.

[78]  Elgene Lim,et al.  Open Access Research Article Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways , 2022 .

[79]  N. Normanno,et al.  Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV‐Cripto‐1 transgenic mice , 2004, Journal of cellular physiology.

[80]  S. Weiss,et al.  A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells , 2006, Nature Cell Biology.

[81]  J. Smith,et al.  Mesoderm formation in response to Brachyury requires FGF signalling , 1995, Current Biology.

[82]  C. Bianco,et al.  Cripto-1: an embryonic gene that promotes tumorigenesis. , 2010, Future oncology.

[83]  Y. Marikawa,et al.  Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction. , 2011, Stem cells and development.

[84]  Hans Clevers,et al.  β-Catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation , 2003, Development.

[85]  Thomas M. Harris,et al.  Cardiac myocyte differentiation: the Nkx2.5 and Cripto target genes in P19 clone 6 cells , 2005, Functional & Integrative Genomics.

[86]  A. Ebert,et al.  Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. , 2000, Experimental cell research.

[87]  Morag H. Stewart,et al.  Human embryonic stem cells: lessons from stem cell niches in vivo. , 2008, Regenerative medicine.

[88]  C. Bianco,et al.  beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. , 2007, Biochemical and biophysical research communications.

[89]  Shiguo Liu,et al.  Teratocarcinoma-derived growth factor 1 (TDGF1) sequence variants in patients with congenital heart defect. , 2011, International journal of cardiology.

[90]  Sophia Hsin-Jung Li,et al.  Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.

[91]  M. Asashima,et al.  Maternal Wnt11 Activates the Canonical Wnt Signaling Pathway Required for Axis Formation in Xenopus Embryos , 2005, Cell.

[92]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[93]  W. Vale,et al.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[94]  D. Constam,et al.  Cripto promotes A–P axis specification independently of its stimulatory effect on Nodal autoinduction , 2008, The Journal of cell biology.

[95]  A. Arai,et al.  Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells. , 2009, The American journal of pathology.

[96]  N. Kosheleva,et al.  Study of angiogenic potential of human multipotent mesenchymal stromal cells , 2013 .

[97]  M. Hendrix,et al.  Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness , 2006, Nature Medicine.